Home
>
National Drug Code (NDC)
>
Nora BE
Nora BE - 52544-629-28 - (Norethindrone)
Drug Information of Nora BE
| Product NDC: | 52544-629 |
| Proprietary Name: | Nora BE |
| Non Proprietary Name: | Norethindrone |
| Active Ingredient(s): | .35 mg/1 & nbsp; Norethindrone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nora BE
| Product NDC: | 52544-629 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017060 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20050512 |
Package Information of Nora BE
| Package NDC: | 52544-629-28 |
| Package Description: | 6 PACKAGE in 1 CARTON (52544-629-28) > 28 TABLET in 1 PACKAGE |
NDC Information of Nora BE
| NDC Code | 52544-629-28 |
| Proprietary Name | Nora BE |
| Package Description | 6 PACKAGE in 1 CARTON (52544-629-28) > 28 TABLET in 1 PACKAGE |
| Product NDC | 52544-629 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Norethindrone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20050512 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | NORETHINDRONE |
| Strength Number | .35 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
